Akarna Therapeutics Ltd acquired by Allergan plc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Allergan (AGN) is on A Major Buying Spree... And It's Just Getting Started
September 20, 2016 4:46 PM EDTAllergan (NYSE: AGN) is wasting little time spending the $29 billion in net cash proceeds it received from the generics sale to Teva. The company has announced four deals since the start of September, including two in the last 12 hours:
09/06 - Allergan plc (NYSE: AGN) agreed to acquire RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore... More